-
Earnings Scheduled For May 18 (BJ, DE, TGT, AAP, SPLS, ROST, JACK, LTD, CHS, ABMD, PETM, BRC, HOTT, ANF, ALKS, EV, NTES, CCM, SNPS)
Wednesday, May 18, 2011 - 1:16am | 504BJ's Wholesale Club Inc (NYSE: BJ) is estimated to post its Q1 earnings at $0.56 per share on revenue of $2.82 billion. Deere & Company (NYSE: DE) is projected to report its Q2 EPS at $2.06 on revenue of $8.14 billion. Target Corp (NYSE: TGT) is estimated to report its Q1 earnings at $0.94...
-
Celldex Thera Drops 13% After Share Offering
Tuesday, May 17, 2011 - 4:07pm | 129Celldex Therapeutics (NASDAQ: CLDX) today announced that it is offering shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by Celldex. The offering is subject to market conditions, and there can be no assurance as to whether or when the...
-
UPDATE: Amgen Announces Phase 3 Data Demonstrate XGEVA is First Bone Targeted Therapy to Prevent Spread of Cancer to the Bone in Men With Advanced Prostate Cancer
Tuesday, May 17, 2011 - 4:04pm | 76Amgen (NASDAQ: AMGN) today announced primary results of a pivotal Phase 3 trial demonstrating that XGEVA significantly increased bone metastasis-free survival for more than four months in men with castrate-resistant metastatic prostate cancer that has not yet spread to bone. Full results of the '...
-
Celldex Announces Public Offering of Common Stock
Tuesday, May 17, 2011 - 4:00pm | 104Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that it is offering shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by Celldex. The offering is subject to market conditions, and there can be no assurance as to whether or when...
-
Nymox Pharmaceutical Announces New Positive Data on NX-1207 Presented at Symposium at American Urological Association Annual Meeting
Tuesday, May 17, 2011 - 2:31pm | 130Nymox Pharmaceutical Corporation (Nasdaq: NYMX) reports on the presentation of new positive data at a high-level symposium and panel discussion held at the Annual Meeting of the American Urological Association in Washington D.C. The symposium was held between 1:30 and 2:30 pm EDT on Tuesday. The...
-
10 Stocks Billionaire Steven Cohen Is Buying
Tuesday, May 17, 2011 - 2:00pm | 246(TheStreet) -- Steven Cohen's SAC Capital, known for its trading-oriented style to investing, made big bets in the first quarter while adding to key positions in Newmont Mining (NYSE: NEM) and communications company CenturyLink (NYSE: CTL). Cohen's Stamford, Conn.-based hedge fund firm, which...
-
Biotech/Pharma Stocks News Alert; Hepatitis C Virus (HCV) FDA News from Aethlon Medical, Vertex Pharmaceuticals, Merck & Company
Tuesday, May 17, 2011 - 11:46am | 1602Point Roberts, WA - May 17, 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector trading alert on Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc (VRTX)., Merck & Company, Inc.(NYSE: MRK) announcing FDA updates on...
-
GTx Presents Preclinical Study Results Demonstrating That Capesaris Chronic Treatment Does Not Cause Gynecomastia in Male Primates
Tuesday, May 17, 2011 - 9:04am | 56GTx, Inc. (Nasdaq: GTXI) announced the presentation today of results of a preclinical study demonstrating that Capesaris treatment achieved and maintained castration over the entire 9 month study without evidence of gynecomastia in male cynomolgus monkeys. The data were presented at the Annual...
-
Taglich Brothers Maintains Rating, PT On DARA
Tuesday, May 17, 2011 - 9:01am | 154Taglich Brothers is maintaining its Speculative Buy rating and its $7.15 price target on DARA BioSciences Inc. (NASDAQ: DARA) as it looks to the future of the company's pipeline drugs. Says Taglich, in the report, “DARA's lead pipeline drugs address the markets for neuropathic pain and Type 2...
-
Biotech/Pharma Stocks Alert; Hepatitis C Virus (HCV) FDA News from (OTCBB: AEMD), (NYSE: MRK), (VRTX)
Tuesday, May 17, 2011 - 9:00am | 48Point Roberts, WA - May 17, 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector trading alert on Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc. (VRTX), Merck & Company, Inc.(NYSE: MRK) announcing FDA updates on...
-
Biotech/Pharma Stocks Alert; Hepatitis C Virus (HCV) FDA News from (OTCBB: AEMD), (NYSE: MRK), (VRTX)
Tuesday, May 17, 2011 - 9:00am | 48Point Roberts, WA - May 17, 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector trading alert on Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc. (VRTX), Merck & Company, Inc.(NYSE: MRK) announcing FDA updates on...
-
Goldman Sachs Reports on Alexion Pharmaceuticals (ALXN)
Tuesday, May 17, 2011 - 7:29am | 160Goldman Sachs commented on Alexion Pharmaceuticals (NASDAQ: ALXN) in a report released yesterday. In the report, Goldman Sachs downgraded the company, but remained somewhat positive. Goldman Sachs writes, “We remove ALXN from our Conviction Buy list and replace it with MAKO Surgical, but we...
-
Targacept Announces Proposed Public Offering Of $75M Shares
Tuesday, May 17, 2011 - 7:18am | 196Targacept (NASDAQ: TRGT) announced today that it is offering to sell $75 million in shares of its common stock in an underwritten public offering. Targacept expects to grant the underwriters for the offering an option to purchase additional shares of common stock to cover over-allotments, if any....
-
Micromet Announces Data Published in Journal of Clinical Oncology Highlights Significant Activity of Blinatumomab in Patients with Acute Lymphoblastic Leukemia
Tuesday, May 17, 2011 - 7:16am | 97Micromet, Inc. (Nasdaq: MITI) today announced that data from a Phase 2 clinical trial of the Company's lead product candidate blinatumomab in patients with minimal residual disease positive acute lymphoblastic leukemia were published in the May 16th on-line edition of the Journal of Clinical...
-
Consumer Now in Question 05-16-2011
Monday, May 16, 2011 - 7:03pm | 953Cusick's Corner Breach! Pressure mounts in Washington as the debt ceiling was breached (bad for the postal pension holders), sending the bond markets to their best levels. Government pension holders will be the backstop at least through the summer. In the commodity world, the floods along the...